EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GBR 12909, a Selective Dopamine Transporter Inhibitor, Differentially Modulates Affective, Exploratory and Cognitive Domains in Zebrafish

Camilla W Pretzel iD, Hevelyn S Moraes, Mariana L Müller, Kimberly Fontoura iD, Rossano S Menezes iD, Julia Canzian, Rodrigo E Barreto iD, Cassio M Resmim, Barbara D Fontana iD, Denis B Rosemberg iD

European Journal of Neuroscience · 2026

DOI: 10.1111/ejn.70651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neuroscience, 2026. Verfasst von Camilla W Pretzel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Neuropsychobiology, Department of Biochemistry and Molecular Biology, Natural and Exact Sciences Center, Federal Universit…. Hauptthemen laut MEDLINE: Dopamine Plasma Membrane Transport Proteins, Cognition, Exploratory Behavior, Piperazines. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dopamine plays an important role in several biological functions, such as reward, movement regulation and cognition. Physiological alterations in dopamine transporter (DAT) are related to psychiatric conditions, including bipolar disorder (BD), a condition characterized by intense shifts in mood, behaviour and energy, alternating between manic and depressive states. Administration of GBR 12909, a selective dopamine reuptake inhibitor, has been considered a suitable model to assess BD‐related phenotypes, yet the integration of anxiety‐like, despair‐like, cognitive and spatiotemporal behavioural dimensions has not been systematically evaluated. Here, we evaluated the acute behavioural effects of GBR 12909 using a multidomain behavioural assessment in adult zebrafish. Fish received a single intraperitoneal administration of GBR 12909 (15 mg/kg) and 30 min after, were challenged to the open field test (OFT), light–dark test (LDT), shallow water test (SWT) and Free Movement Pattern Y‐Maze (FMP Y‐Maze). GBR 12909‐treated zebrafish exhibited increased time in homebase during OFT, prominent scototaxis and hyperactivity in LDT, increased immobility and hypolocomotion in SWT, along impaired cognitive flexibility and stereotypical behaviours in the FMP Y‐maze. These data reflect affective and cognitive disturbances consistent with dopaminergic overstimulation that triggers manic‐ and depressive‐like phenotypes, thereby recapitulating behavioural phenotypes relevant to multiple domains affected in BD. Collectively, our findings support that GBR12909 elicits dopaminergic‐driven behavioural phenotypes relevant to multiple domains of BD, providing a translational model for studying the neurobiological bases of DAT inhibition across distinct behavioural domains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dopamine Plasma Membrane Transport ProteinsCognitionExploratory BehaviorPiperazinesBehavior, AnimalDopamine Uptake InhibitorsAffectAnimalsZebrafishMaleMaze Learning

Stichwörter der Autor:innen

affective‐like behaviourcognitiondopamine transporter inhibitionexploratory behaviourworking memory

Substanzen

Dopamine Plasma Membrane Transport ProteinsPiperazinesDopamine Uptake Inhibitorsvanoxerine

Autor:innen und Institutionen

  • Laboratory of Experimental Neuropsychobiology, Department of Biochemistry and Molecular Biology, Natural and Exact Sciences Center, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil.
  • Graduate Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil.
  • Department of Biochemistry and Molecular Biology, Natural and Exact Sciences Center, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil.
  • Department of Structural and Functional Biology (Physiology), Institute of Biosciences of Botucatu, UNESP, Botucatu, Brazil.
  • The International Zebrafish Neuroscience Research Consortium (ZNRC), Slidell, Louisiana, USA.

ORCID-Profile: Camilla W Pretzel, Kimberly Fontoura, Rossano S Menezes, Rodrigo E Barreto, Barbara D Fontana, Denis B Rosemberg

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul

Zitieren

APA

Pretzel, C. W., Moraes, H. S., Müller, M. L., Fontoura, K., Menezes, R. S., Canzian, J., Barreto, R. E., Resmim, C. M., Fontana, B. D., & Rosemberg, D. B. (2026). GBR 12909, a Selective Dopamine Transporter Inhibitor, Differentially Modulates Affective, Exploratory and Cognitive Domains in Zebrafish. European Journal of Neuroscience. https://doi.org/10.1111/ejn.70651

Vancouver

Pretzel CW, Moraes HS, Müller ML, Fontoura K, Menezes RS, Canzian J, et al. GBR 12909, a Selective Dopamine Transporter Inhibitor, Differentially Modulates Affective, Exploratory and Cognitive Domains in Zebrafish. European Journal of Neuroscience. 2026. doi:10.1111/ejn.70651

BibTeX
@article{Pretzel2026,
  author = {Pretzel, Camilla W and Moraes, Hevelyn S and Müller, Mariana L and Fontoura, Kimberly and Menezes, Rossano S and Canzian, Julia and Barreto, Rodrigo E and Resmim, Cassio M and Fontana, Barbara D and Rosemberg, Denis B},
  title = {GBR 12909, a Selective Dopamine Transporter Inhibitor, Differentially Modulates Affective, Exploratory and Cognitive Domains in Zebrafish},
  journal = {European Journal of Neuroscience},
  year = {2026},
  doi = {10.1111/ejn.70651}
}
Kostenlos starten →